BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 30024608)

  • 1. Correlations between claudin-1 and PIGF expressions in retinoblastoma.
    Wang HF; Zheng SF; Chen Y; Zhou ZY; Xu J
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4196-4203. PubMed ID: 30024608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOW EXPRESSIONS OF CLAUDIN-1 AND MMP-2 IN RETINOBLASTOMA CORRELATE WITH HISTOLOGICAL DIFFERENTIATION AND OPTIC NERVE INVASION.
    Wan WC; Jin XM; Zheng GY; Zhang FY; Lv Y; Zhu Y
    J Biol Regul Homeost Agents; 2015; 29(2):373-8. PubMed ID: 26122225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of matrix metalloproteinase-2,matrix metalloproteinase-9 and vascular endothdial growth factor in retinoblastoma and its clinical significance].
    Zhou L; Xu J; Kang J
    Yan Ke Xue Bao; 2010 Aug; 25(1):62-4. PubMed ID: 21166045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress in retinoblastoma: correlations with clinicopathologic features and tumor invasiveness.
    Deepa PR; Nalini V; Mallikarjuna K; Vandhana S; Krishnakumar S
    Curr Eye Res; 2009 Dec; 34(12):1011-8. PubMed ID: 19958119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of MMP-2 and MMP-9 in retinoblastoma and their significance.
    Long H; Zhou B; Jiang FG
    Int J Ophthalmol; 2011; 4(5):489-91. PubMed ID: 22553708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study of expression of p53, c-myc and PCNA in retinoblastoma].
    Yang X; Zhang Z; Zeng Q
    Zhonghua Yan Ke Za Zhi; 1999 Jul; 35(4):252-4, 14. PubMed ID: 11835814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low expression of NR1D1 and NR2E3 is associated with advanced features of retinoblastoma.
    Ding J; Sun J; Ma RQ; Zheng K; Han YN
    Int Ophthalmol; 2024 Mar; 44(1):133. PubMed ID: 38480634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the risk factors for optic nerve invasion in 381 cases of retinoblastoma].
    Ren RJ; Li B; Li LQ; Sun XL
    Zhonghua Yan Ke Za Zhi; 2007 Jun; 43(6):489-92. PubMed ID: 17897523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of C-kit in retinoblastoma: a potential therapeutic target.
    Barry RJ; de Moura LR; Marshall JC; Fernandes BF; Orellana ME; Antecka E; Martins C; Burnier MN
    Br J Ophthalmol; 2007 Nov; 91(11):1532-6. PubMed ID: 17591671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p16(INK4a) expression in retinoblastoma: a marker of differentiation grade.
    Liu Y; Zhong X; Wan S; Zhang W; Lin J; Zhang P; Li Y
    Diagn Pathol; 2014 Dec; 9():180. PubMed ID: 25499675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment and prognostic analysis of retinoblastoma patients with choroid invasion].
    Wang YZ; Huang DS; Shi JT; Ma JM; Li B; Xu XL; Hu HM; Zhou Y; Gu HL
    Zhonghua Er Ke Za Zhi; 2016 Nov; 54(11):819-822. PubMed ID: 27806788
    [No Abstract]   [Full Text] [Related]  

  • 12. Histopathological features and P-glycoprotein expression in retinoblastoma.
    Filho JP; Correa ZM; Odashiro AN; Coutinho AB; Martins MC; Erwenne CM; Burnier MN
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3478-83. PubMed ID: 16186322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A clinicopathological study of 297 cases of retinoblastoma].
    Yang H; Schilling H; Effert R; Wessing A
    Zhonghua Yan Ke Za Zhi; 1999 Jul; 35(4):255-7, 15. PubMed ID: 11835815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of motility-related protein MRP1/CD9, N-cadherin, E-cadherin, alpha-catenin and beta-catenin in retinoblastoma.
    Mohan A; Nalini V; Mallikarjuna K; Jyotirmay B; Krishnakumar S
    Exp Eye Res; 2007 Apr; 84(4):781-9. PubMed ID: 17316610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinico-pathological correlations of fatty acid synthase expression in retinoblastoma: an Indian cohort study.
    Vandhana S; Deepa PR; Jayanthi U; Biswas J; Krishnakumar S
    Exp Mol Pathol; 2011 Feb; 90(1):29-37. PubMed ID: 21111730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of high-risk features of primary enucleation of patients with retinoblastoma in a tertiary center of a developing country in the era of intra-arterial chemotherapy.
    Dikkaya F; Sarıcı AM; Erbek F; Celkan T; Mangan MS; Aydın Ö; Demirkesen C; Pazarlı H
    Int Ophthalmol; 2018 Feb; 38(1):151-156. PubMed ID: 28058667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Iris neovascularization, increased intraocular pressure and vitreous hemorrhage as risk factors for invasion of the optic nerve and choroid in children with retinoblastoma].
    Baez KA; Ulbig MW; Cater J; Shields CL; Shields JA
    Ophthalmologe; 1994 Dec; 91(6):796-800. PubMed ID: 7849434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoblastoma: expression of HLA-G.
    Adithi M; Kandalam M; Ramkumar HL; Subramanian A; Venkatesan N; Krishnakumar S
    Ocul Immunol Inflamm; 2006 Aug; 14(4):207-13. PubMed ID: 16911982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of heat shock protein 27 and proliferating cell nuclear antigen in human retinoblastoma.
    Qin D; Tan L; You Q; Liu X
    Contemp Oncol (Pozn); 2013; 17(2):144-9. PubMed ID: 23788981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma.
    Webb AH; Gao BT; Goldsmith ZK; Irvine AS; Saleh N; Lee RP; Lendermon JB; Bheemreddy R; Zhang Q; Brennan RC; Johnson D; Steinle JJ; Wilson MW; Morales-Tirado VM
    BMC Cancer; 2017 Jun; 17(1):434. PubMed ID: 28633655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.